Insights on Issues & Trends that Impact Investments in Healthcare & Life Science Businesses
Part II of our series on private equity investing in dialysis discusses other dialysis companies backed by private equity and highlights some key considerations for investors and companies.
Funded in 2000, U.S. Renal Care (USRC), is another dialysis company…
Continue Reading Private Equity Investing in the Dialysis Sector – Part II
The healthcare and life science markets are in a period of dramatic change.
Despite this change, successful private equity funds can still execute deals and achieve capital growth by implementing the right strategies in the right markets. Join us at …
Since the beginning of 2011, medical diagnostic and monitoring device companies have been performing in an established and even an exceptional manner. To date, these specialized medical device businesses have shown double-digit EPS growth and organic revenue growth in the…
Continue Reading Diagnostic & Monitoring Device Companies Attractive Investment
It is a rare healthcare company that has no regulatory risk exposure in at least a few material areas. As sellers of healthcare companies prepare them for sale, they will need to navigate first the letter of intent (LOI) stage…
Current Trends in Healthcare M&A
Tuesday, September 20, 2011
7:30 – 10 a.m.
The Ritz-Carlton
100 Carondelet Plaza
St. Louis, Missouri
McGuireWoods LLP, Clayton Capital Partners, KPMG, Lockton and the St. Louis RCGA invite you to join us for an …
Accountable Care Organizations (ACOs) have become a catchphrase within today’s healthcare industry. As we have discussed in prior posts, ACOs are intended to be a vehicle for providing physicians and medical centers financial incentives to continue offering high-quality medical services…
Healthcare providers are often the first to feel the effects of Medicaid funding shortfalls. Economic turmoil, federal law and political pressures leave states few options but to slash the rates they pay to providers or take other actions regarding …
Continue Reading The Medicaid Budget Crunch & Its Impact on Healthcare Investing: Part II
Selling a healthcare company is a daunting task that requires significant foresight, planning and expertise in addition to the tremendous amount of time required to consummate a deal. For a first time seller, the process is especially intimidating as the…
A few weeks ago, McGuireWoods hosted our 8th Annual Healthcare & Life Sciences Private Equity & Finance Conference along with co-sponsor McGladrey. The Hon. Bill Frist gave the keynote address. It was a real treat to…
In recent years there has been growing public awareness of end of life decisions and the importance of documenting advance healthcare decisions. In fact, April 16th is National Healthcare Decisions Day, a nationwide educational event founded by McGuireWoods partner …
